GO
Loading...

Illumina Inc

More

  • Stocks to Watch: CHSI, BLK, PNC & More Wednesday, 18 Apr 2012 | 7:54 AM ET

    Take a look at some of Wednesday’s morning movers:

  • JPMorgan Analyst to Host Illumina Investor Dinner Tuesday, 17 Apr 2012 | 4:05 PM ET
    Illumina

    Shareholders of all girth face a host of meetings with the pharmaceutical company currently in the crosshairs of a hostile bid from Swiss drug maker Roche.

  • Illumina Plays Offense & Final Trade  Tuesday, 17 Apr 2012 | 12:55 PM ET

    CNBC's Kayla Tausche reports on Illumina playing offense against Roche's hostile takeover bid, and the FMHR crew share their final trades of the hour.

  • Faber Report: Illumina  Tuesday, 17 Apr 2012 | 9:42 AM ET

    CNBC's David Faber reports the latest details on Illumina's recommendation to shareholders to reject Roche's takeover offer.

  • Stocks to Watch: AVP, AOL, MSFT & More Monday, 9 Apr 2012 | 7:47 AM ET

    Take a look at some of Monday’s morning movers:

  • Stocks to Watch: IBM, GE, YHOO & More Wednesday, 4 Apr 2012 | 7:53 AM ET

    Take a look at some of Wednesday’s morning movers:

  • Red Hat, Illumina and Other Midday Movers Thursday, 29 Mar 2012 | 1:36 PM ET

    Find out what’s going up, what’s going down and whether our traders would double down, fade or run in the other direction!

  • Stocks to Watch: RHT, PAYX, FOSL & More Thursday, 29 Mar 2012 | 7:53 AM ET

    Take a look at some of Thursday’s morning movers:

  • Stocks to Watch: HPQ, ILMN, LGF & More Monday, 26 Mar 2012 | 7:48 AM ET

    Take a look at some of Monday morning’s early movers:

  • What's Shaking: Monday's Early Movers Monday, 27 Feb 2012 | 8:39 AM ET

    Take a look at some of Monday morning's early movers:

  • Considering Illumina just adopted a poison pill defense strategy, you might think a deal with Roche is out of the question. But Karen Finerman says it's not.

  • Finerman's Fine Print: Illumina Rejects Roche  Wednesday, 8 Feb 2012 | 5:29 PM ET

    Karen Finerman, Metropolitan Capital Advisors, and Fast Money trader, provides insight on what's next for Illumina, on the heels its recent rejection of Roche's offer.

  • Roche Offer for Illumina Fair, Compelling: CEO Friday, 3 Feb 2012 | 12:44 PM ET

    Roche is willing to spend $5.7 billion on what could be a hostile takeover of Illumina to get into the gene-sequencing market, CEO Severin Schwan told CNBC Friday.

  • Roche CEO on Illumina Deal  Friday, 3 Feb 2012 | 11:25 AM ET

    Insight on the value that will be created by a transaction with Illumina, with Severin Schwan, Roche CEO, who discusses Roche's offer for Illumina.

  • Following are moves you might have missed. Find out why shares of  D.R. Horton and Honeywell popped while Illumina and Altria dropped.

  • Major Wave of Biotech Mergers Expected Thursday, 26 Jan 2012 | 2:48 PM ET

    Amgen and Celgene, looking to boost oncology offerings, announced separate deals for small biotech companies Thursday, the latest in what analysts expect to be a major wave of biotech mergers.

  • Stocks End Sharply Higher After Fed News Wednesday, 25 Jan 2012 | 7:57 PM ET

    Stocks ended near session highs Wednesday, reversing their early declines, as the market cheered news that the Fed will not raise interest rates until at least 2014 in addition to maintaining its highly accommodative stance to support the recovery.

  • Ways to Win In This Market Wednesday, 25 Jan 2012 | 6:43 PM ET

    Cramer ticks off the many winning trades today.

  • Finerman’s Fine Print: Roche Hostility Wednesday, 25 Jan 2012 | 6:29 PM ET

    Illumina landed squarely on Karen Finerman’s trader radar Wednesday with the company in the cross hairs of a hostile bid from Roche.

  • Roche Makes $5.7B Bid for Illumina  Wednesday, 25 Jan 2012 | 5:21 PM ET

    Keith Moore, MKM Partners, discusses how to play Roche's hostile bid for gene sequencer, Illumin, saying ILMN is likely to fight the takeover. Also an update on SanDisk's earnings, with the Fast Money crew.